Of the top neurology drugs with the highest reportedadherence on Medisafe, GSK and Biogen each hold two spots.
Parkinson’s
Parkinson’s
Epilepsy
Epilepsy
Relapsing MS
Epilepsy
MS
MS
MS
Seizures
Sinemet
Requip
Depakene
Keppra
Tecfidera
Ativan
Avonex
Gilenya
Rebif
Lamictal
Merck
Glaxo Smith Kline
AbbVie
UCB
Biogen
Valeant
Biogen
Novartis
EMD Serono
Glaxo Smith Kline
BrandCondition Company
84%
87%
93%
93%
91%
78%
78%
83%
84%
70%
Adherence
?25+1+35+12+22+5+C5%
Worried about side
effects
1%Worried about cost
12%Ran out of meds
35%Forgot/med not nearby
25%Didn’t need dose
22%Other
Neuro medication adherence peaks in the morning hours - but unlike some therapeutic areas it stays relatively high throughout the day.
64 5 7 8 9 10 11 12 1 2 3 4 5 6 7 89 10
AM PM
85%
80%
75%
65%
Mexico78%
Brazil80%
Switzerland
Belgium
Argentina83% Australia
79%
79%
79% Russia84%
Germany
Turkey
77%
78%
78%
USA
The U.S. trails other nations in reported neuro medication adherence on Medisafe.
S M T TW F S79% 79%79% 79%
78%77%
76%
Like many therapeutic areas, Saturday and Sunday prove the most challenging for neuro medication adherence.
50% Average adherence across all therapeutic classes without Medisafe2
82%
80%
78%
76%
74%
Epilepsy | Migraines
Anticonvulsants
Multiple Sclerosis
Alzheimer’s / Dementia
Parkinson’s
Worldwide medication adherence rates for most neurology conditions average 78% on Medisafe.
77+23+K 86+14+K86%84+16+K84%81+19+K81%79+21+K78+22+K 79%78%77%75+25+K75%
Top Neuro Companies by Highest Adherence
Top Neuro Meds with Highest Adherence
Adherence Rates by Type of Neuro Treatment
How Day of Week Affects Neuro Adherence
Top Adherent Countries for Neuro Meds
Medisafe Reported Neurology Drug Adherence by Company
Medisafe Reported Neurology Drug Adherence by Drug Name5
Medisafe Reported Neurology Drug Adherence by Condition
Medisafe Reported Neurology Drug Adherence by Geography
Medisafe Reported Neurology Drug Adherence by Day
How Hour of Day Affects Neuro Adherence
Medisafe Reported Neurology Adherence by Hour
Why Neuro Patients Say They Miss Doses
Medisafe Members’ Reported Reasons for Skipping a Dose
Medisafe, the leading personalized medication management platform addressing all major causes of
non-adherence, delivers better medication adherence1, with more than 750M doses managed.
Neurology Adherence Data:
Real-time stats on Medisafe that pharma should know
Medisafe is the leading personalized medication management platform addressing all major causes of non-adherence.
Far more than a pill reminder app, Medisafe is a cloud-based platform that personalizes content, resources and interventions
— such as educational videos, coupons and motivational messages — based on each user’s regimen, condition and specific
circumstance. Visit medisafe.com/pharma for more information.
1) Medisafe demonstrates up to 20% increase in med adherence in IMS study, presented at ISPOR.2) Medication Adherence in developed countries averages 50%, and is lower in developing regions (WHO). Source: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf3) Medisafe reported adherence of active users that approved notification with more than 3 doses taken from the first take to the last take in relation to scheduled doses.4) Patients are generally considered adherent to their medication if their medication adherence percentage, defined as the number of pills absent in a given time period (“X”) divided by the number of pills prescribed by the physician in that same time period, is greater than 80%. (NIH). Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068890/#R65) Some neurology medications are only infused at a medical center or physician’s office over weekly or monthly intervals, and thereby not represented in this adherence data.
Find out how you can get behavioral insights and answers from the 4 million patients who are using Medisafe’s medication management platform.
Looking for additional insights?
medisafe.com/insights